Flare Therapeutics
68 employees
Biotech/Pharma
Series B · $205.0M
Open positions (1)
Company details
Team Size68
IndustryBiotech/Pharma
Funding
Total raised
$205.0M
Last stage
Series B
Investors
GordonMD Global Investments
Total raised
$205.0M
Last stage
Series B
Investors
Robert Sims
Industry leader in drug discovery of gene control. Former entrepreneur-in-residence at Third Rock Ventures and founding scientist/SVP of Research at Constellation Pharmaceuticals. Ph.D. in Cellular and Molecular Biology from the University of Texas at Austin.
Fraydoon Rastinejad
Scientific co-founder inspired by seminal work on the HIF2A transcription factor at Oxford University. Elucidated the structural basis for bidirectional tuning of gene regulation by HIF2A using small molecules.
Mitchell Lazar
Scientific co-founder of Flare Therapeutics, with expertise in transcription factor biology.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.